< Back to latest news & events

Event

IQPC Global IP Exchange Europe 2021

March 2021

Event date: 9th March 2021

HGF is attending IQPC Global IP Exchange Europe 2021 virtual event being held 9 – 10 March 2021.

The Global IP Exchange exclusively brings together 90 expert Chief IP Counsel, Heads and Global Directors responsible for IP, Patent, Licensing, Trademark and Brand Protection, to discover creative ideas and establish new, professional relationships to help grow your IP strategy in to the next decade.

HGF Partners Alexander Hagen, Dr Chris Benson & Pieter de Ruijter will be attending the event and Lucy Johnson will be hosting.

Find out more

Attendees

Christopher
Benson

Lucy
Johnson

Alexander
Hagen

Pieter
de Ruijter

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
See all updates